News

C&EN29d
Discovery and Optimization of 1-(4-(Pyridin-2-yl)benzyl)imidazolidine-2,4-dione Derivatives As a Novel Class of Selective Cannabinoid CB2 Receptor Agonists
§ Department of Molecular Pharmacology & DMPK, Merck Research Laboratories, Oss, The Netherlands ∥ Department of Molecular Pharmacology, Merck Research Laboratories, Newhouse, Scotland ⊥ Department of ...